Irvine, California – October 12, 2020 /MarketersMedia/ —
Galexxy Corporation (“Galexxy” or the “Company”), a private company incorporated under the laws of California, plans to disrupt the $5 billion CBD market with a proprietary range of high-quality CBD healthcare products and a unique, incentive-based mass marketing plan.
Galexxy is offering a maximum of four million (4,000,000) shares at $0.25 per share. This offering is being made in California only to qualified purchasers, as are defined by Section 25102(n)(2) of the California Corporations Code. Net proceeds from the offering will be used to fund production of initial inventory, business operations and roll out of its patent pending Virtual Retail Marketing System™ to several thousand retail and business outlets.
Galexxy has signed a Letter of Intent to be acquired by a publicly traded entity and Investors in this offering per the Letter of Intent, will receive an offer to exchange their shares on a 1:5 basis for shares in the publicly traded entity. Shareholders can expect a liquid public market for their shares in the second half of 2021. A full disclosure is provided for all interested, qualified purchasers in the form of the Company’s Offering Document.
Galexxy is a CBD manufacturing and online marketing company specializing in the development of high-quality CBD full spectrum refined oil and CBD isolate proprietary products using its unique, patent-pending Virtual Retail Marketing System™ (VRMS). The VRMS is designed to enable rapid, mass marketing of its online CBD product range via thousands of business and retail outlets that connect with millions of consumers.
According to Ross Lyndon-James, Galexxy’s CEO, “The CBD market is overpriced and ripe for disruption. It’s a hot market and predicted to grow by 500% in the next few years. With millions of people out of work, Galexxy’s Virtual Retail Marketing System creates a unique, financial opportunity for individuals, business professionals and retail outlets to generate income without any cost or financial risk.”